Comparison of four validated psoriatic arthritis screening tools in diagnosing psoriatic arthritis in patients with psoriasis (COMPAQ Study)

Mishra, Sushanta Kumar; Kancharla, Harish; Dogra, Sunil; Sharma, Aman

doi:10.1111/bjd.14929

Cited by 51 publications

(45 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These first findings demonstrate the good diagnostic properties of the PURE‐4, comparable to the recently reported high performance obtained with the EARP questionnaire in Indian patients, but using only four easy‐to‐collect items with no need for training required for its implementation. Special attention was given to compatibility with outpatient dermatology practice, where the instrument can be completed by patients in the waiting room and reviewed with the dermatologist during consultation for final scoring and potentially help decision‐making.…”

Section: Introductionsupporting

confidence: 77%

Psoriatic arthritis screening by the dermatologist: development and first validation of the ‘PURE‐4 scale’

Audureau

Roux²,

Danic

et al. 2018

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

Section: Introductionsupporting

confidence: 77%

Psoriatic arthritis screening by the dermatologist: development and first validation of the ‘PURE‐4 scale’

Audureau

Roux²,

Danic

et al. 2018

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…Psoriasis affects ~3% of the population, and ~30% of patients with psoria sis will develop PsA (2). Given the high rates of undiagnosed and undertreated PsA among individuals with psoriasis, early screening is used to improve access to early treatment and prevent joint damage (3). Patients with PsA and psoriasis have a higher risk of comorbidities, including depression, metabolic disease, and cardiovascular mortality compared with the gen eral population (4).…”

Section: Introductionmentioning

confidence: 99%

Patients’ Perspectives and Experience of Psoriasis and Psoriatic Arthritis: A Systematic Review and Thematic Synthesis of Qualitative Studies

Sumpton

Kelly

Tunnicliffe

et al. 2020

Arthritis Care & Research

View full text Add to dashboard Cite

Objective. To describe the range and depth of perspectives and experiences of patients with psoriasis and psoriatic arthritis to inform gaps in patient-centered care.Methods. We searched MEDLINE, Embase, PsycINFO, and CINAHL to April 2018. Thematic synthesis was used to analyze the findings.Results. We included 56 studies involving 1,484 adult patients with psoriasis (n = 1,147) and psoriatic arthritis (n = 337). Six themes (and subthemes) were identified: suffering uncontrollable and ongoing upheaval (dictating life choices and course, disrupting family and social roles, limited by debilitating symptoms, unstoppable and far-reaching fatigue), weighed down by mental load (anxiety provoked by the volatility of symptoms, dreading deterioration, struggling with unrecognized distress, helpless and nihilistic), harboring shame and judgement (marked as unhygienic and contagious, rejected and isolated, hiding away and resenting own appearance, pain and embarrassment in intimacy), demoralized by inadequacies and burden of therapy (disappointed by unmet expectations of treatment benefit, daily drudgery, deterred by unpalatable or inconvenient treatments, disempowered by lack of personalized care), gaining control (making sense of the condition, accepting a new health status, regaining independence and normality, attuning to the body), and making confident treatment decisions (trading off perceptible benefits against safety and convenience, relying on family input, seeking empowering and reassuring relationships).Conclusion. Patients with psoriasis and psoriatic arthritis contend with disruption in their functioning, roles, and life course and have unmet expectations about treatment. Enhanced therapeutic relationships, addressing treatment expectations and supporting psychosocial needs may improve satisfaction and outcomes.

show abstract

“…Zahlreiche Tools zum Screening und zur Erhebung der Krankheitsaktivität in der Diagnostik als auch im weiteren Verlauf stehen zur Verfügung [69]. Eine aktuelle Studie [70] Eine Beobachtungstudie mit 410 PsC-Patienten widmet sich der Prädiktion einer PsA [71]. Die mittlere Nachbeobachtungszeit umfasste 46 Monate, wo 57 (13.9 %) eine PsoA entsprechend der Klassifikationskriterien mit axialen als auch peripheren Befallsmuster entwickelten [72].…”

Section: Auswahl Klinischer Und Diagnostischer Ergebnisse Bei Psaunclassified

Auswahl klinischer und diagnostischer Ergebnisse bei entzündlichen Gelenkerkrankungen

Detert

2018

Akt Rheumatol

View full text Add to dashboard Cite

ZusammenfassungZahlreiche Fortschritte in der Grundlagenforschung, in der Diagnostik und Therapie in den letzten Jahren führen dazu, dass Patienten mit einer entzündlichen Gelenkerkrankung eine Remission bzw. niedrigstmögliche Krankheitsaktivität, Lebensqualität, einen Erhalt ihrer Arbeitsfähigkeit als auch das Beibehalten der sozialen Integration beibehalten. Diese Erfolge werden schrittweise versucht, auf andere Autoimmunerkrankungen zu übertragen. Es zeigt sich gerade auf dem Gebiet der Medikamentenentwicklung jedoch immer wieder, dass es sich um pathogenetisch unterschiedlich verursachte Erkrankungen handelt und Therapieerfolge nicht immer gleichermaßen erreichbar sind. Jedoch sind inzwischen zahlreiche Medikamente zur Behandlung der entzündlichen Gelenkerkrankungen verfügbar, weitere werden derzeit intensiv in klinischen Studien geprüft bzw. sind zur Zulassungsentscheidung bei den Aufsichtsbehörden registriert. So sind auch in den nächsten Jahren weitere Therapiemöglichkeiten zu erwarten. Die rheumatoide Arthritis ist ein Beispiel dieser Erfolgsgeschichte, so dass inzwischen sogar die Frage diskutiert wird, ob diese Erkrankung präventiv zu behandeln und somit die Manifestation der Erkrankung zu stoppen ist. Diese Übersicht vermittelt eine Auswahl aktueller Forschungsergebnisse und Medikamentenentwicklungen bei entzündlichen Gelenkerkrankungen.

show abstract

Comparison of four validated psoriatic arthritis screening tools in diagnosing psoriatic arthritis in patients with psoriasis (COMPAQ Study)

Abstract: EARP was found to have the best sensitivity; ToPAS II had the highest specificity. A major limitation of the study design was the exclusion of pre-existing rheumatological diseases.

Cited by 51 publications

References 19 publications

Psoriatic arthritis screening by the dermatologist: development and first validation of the ‘PURE‐4 scale’

Psoriatic arthritis screening by the dermatologist: development and first validation of the ‘PURE‐4 scale’

Patients’ Perspectives and Experience of Psoriasis and Psoriatic Arthritis: A Systematic Review and Thematic Synthesis of Qualitative Studies

Auswahl klinischer und diagnostischer Ergebnisse bei entzündlichen Gelenkerkrankungen

Contact Info

Product

Resources

About